Nevertheless, data from our and other groups demonstrate that tumor plasma cells produce relatively low quantities of HB-EGF that are negligible compared with those produced by bone marrow stromal cells such as endothelial cells [16]. The gene discussed is HBEGF; the disease is neoplasm.